Case 12 — Metabolic & Immune: Combined Cell Program

Program design

A personalized combined program for clients with metabolic syndrome indicators: MSC (mesenchymal stem cell) infusions for tissue repair and metabolic balance, followed by NKM immune cell expansions for inflammatory control.

Protocol example

Monthly MSC infusions (5×10⁷ cells) over a 4-month phase, followed by NKM immune cell sessions (4-6×10⁹ cells) in months 5-6. Each phase includes pre-infusion health assessment and post-infusion tracking.

Observed context

Clients with Type-2 diabetes, fatty liver, elevated triglycerides and uric acid participated in documented programs. High-glucose environments are noted in program literature as unfavorable for normal tissue function — the program targets restoring metabolic balance.

Document chain

Full informed-consent records, batch release documents, and infusion logs maintained per program. Cell products prepared on the closed platform with per-batch characterization.

Observational records from internal application programs, anonymized. Individual results vary. These notes describe program design contexts and are not medical advice, nor a promise of outcomes.